Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes
Abstract
The Fmr1 knockout (KO) mouse is characterized by an increased audiogenic seizure (AGS) susceptibility and is considered a good animal model for epilepsy and seizures in the human fragile-X (FRAX) syndrome. Here, we tested the hypothesis that the reintroduction of the FMR1 gene is able to revert the AGS susceptibility characterizing Fmr1 KO mice. To this aim, two groups of Fmr1 KO transgenic mice, which have additional copies of the human FMR1 gene (YAC) or FMR1 cDNA (G6) were used. AGS susceptibility of these mice was examined and compared to that of Fmr1 KO, wild type, and wild-type animals in whom the FMR1gene was also introduced (over-expressed). Mice were tested at different ages because AGS susceptibility is age dependent. The intensity of response was scored and the results were analyzed by means of 2-way analysis of variance to evaluate the effects of age and genetic condition. We found that AGS susceptibility rescue is complete in the G6 mice and partial in YAC mice. Our data indicate that the introduction of the human FMR1 gene in Fmr1 KO mice is able to revert the Fmr1 KO epileptic phenotype.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fmr1 knockout mice exhibit auditory hypersensitivity, including audiogenic seizures and enhanced cortical responses to sounds.
“Fmr1 knockout (KO) mouse, a pre-clinical model of FXS, also exhibits auditory hypersensitivity including audiogenic seizures (Chen and Toth, 2001; Musumeci et al., 2007) and enhanced cortical responses to sounds (Rotschafer and Razak, 2013).”
From Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome (2016) · cites this paper as Musumeci et al., 2007
Cites
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,075 · see citing works
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046 · see citing works
Self-citationDevys, D., Lutz, Y., Rouyer, N., Bellocq, J., & Mandel, J. (1993) · Nature Genetics · doi:10.1038/ng0893-335 · Cited by 781 · see citing works
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676 · see citing works
Self-citationThe protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
Siomi, H., Siomi, M. C., Nussbaum, R. L., & Dreyfuss, G. (1993) · Cell · doi:10.1016/0092-8674(93)90420-u · Cited by 641 · see citing works
Evidence that fragile X mental retardation protein is a negative regulator of translation
Laggerbauer, B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.329 · Cited by 571 · see citing works
Feng, Y., Gutekunst, C.-A., Eberhart, D. E., Yi, H., Warren, S. T., & Hersch, S. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01539.1997 · Cited by 532 · see citing works
Analysis of neocortex in three males with the Fragile X syndrome
Hinton, V. J., Brown, W. T., Wisniewski, K., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320410306 · Cited by 527 · see citing works
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521 · see citing works
Fragile X Syndrome: Diagnosis, Treatment, And Research
Silverman, & Cronister, A. (1991) · Johns Hopkins University Press eBooks · Cited by 481 · see citing works
From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome
Bagni, C., & Greenough, W. T. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1667 · Cited by 475 · see citing works
The fragile X mental retardation protein inhibits translation via interacting with mRNA
Li, Z. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.11.2276 · Cited by 448 · see citing works
Eberhart, D. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.8.1083 · Cited by 390 · see citing works
Rousseau, F., Rouillard, P., Morel, M. L., Khandjian, E. W., & Morgan, K. (1995) · Europe PMC (PubMed Central) · Cited by 361 · see citing works
Fragile X mice develop sensory hyperreactivity to auditory stimuli
Chen, L., & Toth, M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00036-7 · Cited by 345 · see citing works
Lu, R., Wang, H., Liang, Z., Ku, L., O'Donnell, W. T., Li, W., Warren, S. T., & Feng, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404995101 · Cited by 322 · see citing works
Audiogenic Seizures Susceptibility in Transgenic Mice with Fragile X Syndrome
Musumeci, S. A., Bosco, P., Calabrese, G., Bakker, C., De Sarro, G. B., Elia, M., Ferri, R., & Oostra, B. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb01499.x · Cited by 289 · see citing works
Self-citationDombrowski, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.371 · Cited by 289 · see citing works
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features
Peier, A. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1145 · Cited by 285 · see citing works
Abitbol, M. M., Ménini, C., Delezoide, A., Rhyner, T. A., Vekemans, M. J. J., & Mallet, J. J. (1993) · Nature Genetics · doi:10.1038/ng0693-147 · Cited by 284 · see citing works
Epilepsy in fragile X syndrome
Berry‐Kravis, E. (2002) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2002.tb00277.x · Cited by 271 · see citing works
The fragile X mental retardation protein is associated with ribosomes
Khandjian, E. W., Corbin, F., Woerly, S., & Rousseau, F. (1996) · Nature Genetics · doi:10.1038/ng0196-91 · Cited by 251 · see citing works
Epilepsy and EEG Findings in Males with Fragile X Syndrome
Musumeci, S. A., Hagerman, R. J., Ferri, R., Bosco, P., Bernardina, B. D., Tassinari, C. A., Sarro, G. D., & Elia, M. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00824.x · Cited by 250 · see citing works
Self-citationA phenotypic and molecular characterization of the <i>fmr1‐tm1Cgr</i> Fragile X mouse
Yan, Q. J., Asafo‐Adjei, P. K., Arnold, H. M., Brown, R. E., & Bauchwitz, R. P. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2004.00087.x · Cited by 213 · see citing works
Decreased GABAA receptor expression in the seizure-prone fragile X mouse
Idrissi, A. E., Ding, X., Scalia, J., Trenkner, E., Brown, W. T., & Dobkin, C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.087 · Cited by 210 · see citing works
Immunocytochemical and Biochemical Characterization of FMRP, FXR1P, and FXR2P in the Mouse
Bakker, C. E., de Diego‐Otero, Y., Bontekoe, C. J. M., Raghoe, P., Luteijn, T., Hoogeveen, A. T., Oostra, B. A., & Willemsen, R. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4932 · Cited by 193 · see citing works
Self-citationChuang, S.-C., Zhao, W., Bauchwitz, R., Yan, Q., Bianchi, R., & Wong, R. K. S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1777-05.2005 · Cited by 190 · see citing works
Gantois, I., Vandesompele, J., Speleman, F., Reyniers, E., D’Hooge, R., Severijnen, L.-A. W. F. M., Willemsen, R., Tassone, F., & Kooy, R. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.017 · Cited by 166 · see citing works
Fragile X syndrome: diagnosis, treatment and research
Vries, B. B. A. D. (2003) · Human Genetics · doi:10.1007/s00439-002-0888-y · Cited by 163 · see citing works
Wang, H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh009 · Cited by 117 · see citing works
Autistic Spectrum Disorder and the Fragile X Premutation
Goodlin‐Jones, B. L., Tassone, F., Gane, L. W., & Hagerman, R. J. (2004) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200412000-00002 · Cited by 115 · see citing works
Genetic dissection of susceptibility to audiogenic seizures in inbred mice.
Neumann, P. E., & Collins, R. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5408 · Cited by 113 · see citing works
Gabel, L. A., Won, S., Kawai, H. D., McKinney, M., Tartakoff, A. M., & Fallon, J. R. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2185-04.2004 · Cited by 103 · see citing works
Neuropathologic findings associated with seizures in FVB mice.
Goelz, M. F., MAHLER, J. F., Harry, J. L., Myers, P. C., Clark, J., Thigpen, J. E., & Forsythe, D. B. (1998) · PubMed · Cited by 89 · see citing works
Involvement of cholinergic and gabaergic systems in the fragile X knockout mice
D’Antuono, M., Merlo, D., & Avoli, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00103-9 · Cited by 64 · see citing works
Restoring the Phenotype of Fragile X Syndrome: Insight from the Mouse Model
Gantois, I., Bakker, C. E., Reyniers, E., Willemsen, R., D’Hooge, R., Deyn, P. D., Oostra, B. A., & Kooy, R. F. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363492 · Cited by 29 · see citing works
Self-citationBIT-mapped somatosensory evoked potentials in the fragile X syndrome
Ferri, R., Musumeci, S. A., Elia, M., Gracco, S. D., Scuderi, C., & Bergonzi, P. (1994) · Neurophysiologie Clinique · doi:10.1016/s0987-7053(05)80074-7 · Cited by 24 · see citing works
Self-citationLong‐term potentiation in the hippocampus of fragile X knockout mice
Godfraind, J., Reyniers, E., Boulle, K. D., D’Hooge, R., Deyn, P. P. D., Bakker, C. E., Oostra, B. A., Kooy, R. F., & Willems, P. J. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960809)64:2 · Cited by 16 · see citing works
Self-citationAnimal models of schizophrenia
Hert, M. D., & Ellenbroek, B. A. (2000) · Neuroscience Research Communications · doi:10.1002/1520-6769(200005/06)26:3 · Cited by 6 · see citing works
Self-citationBeskow, A. H., Emahazion, T., Prince, J. A., Angelini, C. I., & Brookes, A. J. (2000) · Gene Function & Disease · doi:10.1002/1438-826x(200005)1:1
Self-citationIrwin (2001) · doi:10.1002/1096-8628(20010115)98:2
Flagged first, then by citations
Cited by
Sorted by citations
Dolan, B. M., Duron, S. G., Campbell, D. A., Vollrath, B., Rao, B. S. S., Ko, H.-Y., Lin, G. G., Govindarajan, A., Choi, S.-Y., & Tonegawa, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219383110 · Cited by 260 · see citing works
Gkogkas, C. G., Khoutorsky, A., Cao, R., Jafarnejad, S. M., Prager-Khoutorsky, M., Giannakas, N., Kaminari, A., Fragkouli, A., Nader, K., Price, T. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.064 · Cited by 201 · see citing works
Sinclair, D., Oranje, B., Razak, K. A., Siegel, S. J., & Schmid, S. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.029 · Cited by 198 · see citing works
“Reintroduction of FMRP to Fmr1 KO mice significantly reduced audiogenic seizure susceptibility (Musumeci et al., 2007).”
Early developmental alterations in GABAergic protein expression in fragile X knockout mice
Adusei, D. C., Pacey, L. K. K., Chen, D., & Hampson, D. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.002 · Cited by 139 · see citing works
Altered auditory processing in a mouse model of fragile X syndrome
Rotschafer, S. E., & Razak, K. A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.038 · Cited by 138 · see citing works
Pacey, L. K. K., Heximer, S. P., & Hampson, D. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056127 · Cited by 133 · see citing works
Sensory Processing Phenotypes in Fragile X Syndrome
Rais, M., Binder, D. K., Razak, K. A., & Ethell, I. M. (2018) · ASN NEURO · doi:10.1177/1759091418801092 · Cited by 128 · see citing works
Costa, L., Spatuzza, M., D’Antoni, S., Bonaccorso, C. M., Trovato, C., Musumeci, S. A., Leopoldo, M., Lacivita, E., Catania, M. V., & Ciranna, L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.008 · Cited by 129 · see citing works
Self-citationFragile X syndrome: from molecular genetics to therapy
D’Hulst, C., & Kooy, R. F. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.064667 · Cited by 125 · see citing works
Lovelace, J. W., Wen, T. H., Reinhard, S., Hsu, M. S., Sidhu, H., Ethell, I. M., Binder, D. K., & Razak, K. A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.002 · Cited by 115 · see citing works
Animal and model systems for studying cystic fibrosis
Rosen, B. H., Chanson, M., Gawenis, L. R., Liu, J., Sofoluwe, A., Zoso, A., & Engelhardt, J. F. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.09.001 · Cited by 106 · see citing works
Fragile X Syndrome and Targeted Treatment Trials
Hagerman, R. J., Lauterborn, J. C., Au, J., & Berry‐Kravis, E. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-21649-7_17 · Cited by 104 · see citing works
Fragile X syndrome: From protein function to therapy
Bagni, C., & Oostra, B. A. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36241 · Cited by 104 · see citing works
Self-citationAuditory Processing in Fragile X Syndrome
Rotschafer, S. E., & Razak, K. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00019 · Cited by 103 · see citing works
Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders
Carlson, G. C. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.003 · Cited by 102 · see citing works
Aloisi, E., Corf, K. L., Dupuis, J. P., Zhang, P., Ginger, M. R., Labrousse, V. F., Spatuzza, M., Haberl, M. G., Costa, L., Shigemoto, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01191-2 · Cited by 98 · see citing works
Self-citationBrouwer, J. R., Huizer, K., Severijnen, L.-A. W. F. M., Hukema, R. K., Berman, R. F., Oostra, B. A., & Willemsen, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05747.x · Cited by 99 · see citing works
Self-citationD’Antoni, S., Spatuzza, M., Bonaccorso, C. M., Musumeci, S. A., Ciranna, L., Nicoletti, F., Huber, K. M., & Catania, M. V. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.003 · Cited by 94 · see citing works
Self-citationAssociation between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions
Kim, K., Hessl, D. R., Randol, J. L., Espinal, G. M., Schneider, A., Protic, D. D., Aydin, E. Y., Hagerman, R. J., & Hagerman, P. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226811 · Cited by 75 · see citing works
Zeier, Z. R., Kumar, A., Bodhinathan, K., Feller, J. A., Foster, T. C., & Bloom, D. C. (2009) · Gene Therapy · doi:10.1038/gt.2009.83 · Cited by 68 · see citing works
Gonzalez, D., Tomasek, M. P., Hays, S. A., Sridhar, V., Ammanuel, S. G., Chang, C.-W., Pawlowski, K. S., Huber, K. M., & Gibson, J. R. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0886-19.2019 · Cited by 64 · see citing works
Magdalon, J., Sánchez-Sánchez, S. M., Griesi‐Oliveira, K., & Sertie, A. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030659 · Cited by 58 · see citing works
Gogliotti, R. G., Senter, R. K., Rook, J. M., Ghoshal, A., Zamorano, R., Malosh, C., Stauffer, S. R., Bridges, T. M., Bartolomé, J. M., Daniels, J. S., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw074 · Cited by 57 · see citing works
Pedapati, E. V., Schmitt, L., Ethridge, L. E., Miyakoshi, M., Sweeney, J. A., Liu, R., Smith, E. G., Shaffer, R. C., Dominick, K. C., Gilbert, D. L., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03395-9 · Cited by 54 · see citing works
Emerging Pharmacotherapies for Neurodevelopmental Disorders
Wetmore, D. Z., & Garner, C. C. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181ee3833 · Cited by 54 · see citing works
Li, M., Zhao, H., Ananiev, G. E., Musser, M. T., Ness, K. H., Maglaque, D. L., Saha, K., Bhattacharyya, A., & Zhao, X. (2016) · Stem Cells · doi:10.1002/stem.2463 · Cited by 54 · see citing works
Bonaccorso, C. M., Spatuzza, M., Di Marco, B., Gloria, A., Barrancotto, G., Cupo, A., Musumeci, S. A., D'Antoni, S., Bardoni, B., & Catania, M. V. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.02.004 · Cited by 52 · see citing works
Self-citationPathological plasticity in fragile X syndrome.
Martin, B. S., & Huntsman, M. M. (2012) · Neural Plasticity · doi:10.1155/2012/275630 · Cited by 57 · see citing works
Fragile X Mental Retardation Protein in Learning-Related Synaptic Plasticity
Mercaldo, V., Descalzi, G., & Zhuo, M. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0193-x · Cited by 44 · see citing works
Curia, G., Gualtieri, F., Bartolomeo, R., Vezzali, R., & Biagini, G. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00046 · Cited by 44 · see citing works
The developmental roles of FMRP
Till, S. M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380507 · Cited by 43 · see citing works
Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
Ruby, K., Falvey, K., & Kulesza, R. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.061 · Cited by 41 · see citing works
The role of GABAergic system in neurodevelopmental disorders: a focus on autism and epilepsy.
Sgadó, P., Dunleavy, M., Genovesi, S., Provenzano, G., & Bozzi, Y. (2011) · PubMed Central · Cited by 40 · see citing works
Autism - A Neurodevelopmental Journey from Genes to Behaviour
Eapen, V. (2011) · InTech eBooks · doi:10.5772/974 · Cited by 36 · see citing works
Developmental Emergence of Phenotypes in the Auditory Brainstem Nuclei ofFmr1Knockout Mice
Rotschafer, S. E., & Cramer, K. S. (2017) · eNeuro · doi:10.1523/eneuro.0264-17.2017 · Cited by 30 · see citing works
Nguyen, A. O., Binder, D. K., Ethell, I. M., & Razak, K. A. (2020) · Journal of Neurophysiology · doi:10.1152/jn.00706.2019 · Cited by 28 · see citing works
Fragile X syndrome: from gene discovery to therapy
Heulens, I. (2010) · Frontiers in bioscience · doi:10.2741/3785 · Cited by 31 · see citing works
Mouse models of fragile X-related disorders
Willemsen, R., & Kooy, R. F. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049485 · Cited by 27 · see citing works
Rodent Models of Audiogenic Epilepsy: Genetic Aspects, Advantages, Current Problems and Perspectives
Garbuz, D. G., Davletshin, A. I., Литвинова, С. А., Федотова, И. Б., Surina, N. M., & Полетаева, И. И. (2022) · Biomedicines · doi:10.3390/biomedicines10112934 · Cited by 23 · see citing works
Reactivation of FMR1 gene expression is a promising strategy for fragile X syndrome therapy
Shitik, E. M., Velmiskina, A. A., Dolskiy, A. A., & Yudkin, D. V. (2020) · Gene Therapy · doi:10.1038/s41434-020-0141-0 · Cited by 22 · see citing works
A single early-life seizure results in long-term behavioral changes in the adult Fmr1 knockout mouse
Hodges, S. L., Reynolds, C. D., Nolan, S. O., Huebschman, J. L., Okoh, J. T., Binder, M. S., & Lugo, J. N. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.106193 · Cited by 22 · see citing works
Jiang, Y., Han, L., Meng, J., Wang, Z., Zhou, Y., Yuan, H., Xu, H., Zhang, X., Zhao, Y., Lu, J., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.10.002 · Cited by 19 · see citing works
Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice
Saraf, T. S., Felsing, D. E., Armstrong, J. L., Booth, R. G., & Canal, C. E. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106677 · Cited by 13 · see citing works
Marco, B. D., Dell’Albani, P., D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., Musumeci, S. A., Drago, F., Bardoni, B., & Catania, M. V. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105338 · Cited by 12 · see citing works
Self-citationFrom wings to whiskers to stem cells: why every model matters in fragile X syndrome research
Sandoval, S. O., Méndez-Albelo, N. M., Xu, Z., & Zhao, X. (2024) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09545-w · Cited by 8 · see citing works
Development of a Quantitative FMRP Assay for Mouse Tissue Applications
Adayev, T., LaFauci, G., Xu, W., Dobkin, C., Kascsak, R. J., Brown, W. T., & Goodman, J. H. (2021) · Genes · doi:10.3390/genes12101516 · Cited by 5 · see citing works
Human Pluripotent Stem Cells in Modeling Human Disorders: the Case of Fragile X Syndrome
Vershkov, D., & Benvenisty, N. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0100 · Cited by 5 · see citing works
Spatially coordinated heterochromatinization of distal short tandem repeats in fragile X syndromePreprint
Zhou, L., Ge, C., Malachowski, T., Kim, J. H., Chandradoss, K. R., Chuanbin, S., Wu, H., Rojas, L. A., Wallace, O. B., Titus, K. R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.23.441217 · Cited by 5 · see citing works
Autoimmune RNA dysregulation and seizures: therapeutic prospects in neuropsychiatric lupus
Muslimov, I. A., Berardi, V., Stephenson, S. I., Ginzler, E. M., Hanly, J. G., & Tiedge, H. (2022) · Life Science Alliance · doi:10.26508/lsa.202201496 · Cited by 4 · see citing works
GABAergic Dysfunction in Autism and Epilepsy
Genovesi, S., Provenzano, G., Dunleavy, M., Sgadó, P., & Bozzi, Y. (2011) · InTech eBooks · doi:10.5772/17387 · Cited by 4 · see citing works
Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells
Vershkov, D., Ben‐Hur, T., & Benvenisty, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00006-8 · Cited by 4 · see citing works
O’Leary, H., & Benke, T. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00074-2 · Cited by 2 · see citing works
Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder
Schroeder, J. C., Deliu, E., Novarino, G., & Schmeißer, M. J. (2017) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-52498-6_10 · Cited by 2 · see citing works
Korff, A., Yang, X., Ozdemir, O., Samanta, A., Wang, Y., Patni, T., Lavado, A., Kavirayani, A. M., Ochaba, J., Powers, B. E., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adx3491 · Cited by 1 · see citing works
A microglial basis for fragile X syndrome via impairment of FMRP-regulated lysosomal function
Li, H., Choi, J. J.-Y., Huang, E. J., & Xu, B. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03927-3 · Cited by 1 · see citing works
Chromosomal Abnormalities and Cortical Malformations
Elia, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-04573-9_33 · Cited by 1 · see citing works
Self-citationSynaptic modifications in hippocampal CA3 pyramidal cells in an Alzheimer's mouse model
Zhang, P. (2018) · doi:10.53846/goediss-6752 · Cited by 1 · see citing works
Korff, A., Yang, X., O’Donovan, K., Gonzalez, A., Teubner, B. J. W., Nakamura, H., Messing, J. A., Yang, F., Carisey, A. F., Wang, Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.17.484791 · Cited by 1 · see citing works
Visual Spatial Learning and Memory in Fragile X Syndrome and fmr1 Knockout Mice
MacLeod, L. S. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-6693
Fragile X Syndrome: From Pathophysiology to New Therapeutic Perspectives
D’Antoni, S., Spatuzza, M., Carmela, M., Aloisi, E., Musumeci, S. A., & Vincenza, M. (2012) · InTech eBooks · doi:10.5772/31387
Self-citationBrouwer, J. R. (2008) · RePub (Erasmus University Rotterdam)
Self-citationNeuronal Dysfunction in Fragile X Spectrum Disorders.
Renoux, A. J. (2015) · Deep Blue (University of Michigan)
Chelly, J. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717992196.793473535
Thompson, L. M. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1162995.623635
Li, H., Choi, J. J.-Y., Huang, E. J., & Xu, B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.09.663876
Involvement of mGluR5/Homer crosstalk disruption in the pathophysiology of Fragile X Syndrome
Aloisi, E. (2015) · theses.fr (ABES) · doi:10.70675/e628d840zb6adz4e63z9d1fz71559b23fe24
Synaptic modifications in hippocampal CA3 pyramidal cells in an Alzheimer's mouse model
Zhang, P. (2017) · theses.fr (ABES) · doi:10.70675/74cb83e0z6db8z4bb5z838dz6e1bb1c6275f
Maio, B., Singh, A., Hector, R., Gadalla, K. K. E., Selfridge, J., Aria, F., Louros, S. R., Cobb, S., & Osterweil, E. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.12.731901
- Authors
- Musumeci, S. A., Calabrese, G., Bonaccorso, C. M., D'Antoni, S., Brouwer, J. R., Bakker, C. E., Elia, M., Ferri, R., Nelson, D. L., Oostra, B. A., & Catania, M. V.
- Affiliations
- Oasi Maria SS (IT)
- Erasmus University Rotterdam (NL)
- Baylor College of Medicine (US)
- Corresponding author
- Musumeci, Sebastiano A.
- ORCID
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 203
- Issue
- 1
- Pages
- 233-240
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2134884548
- Cited by
- 70
- References
- 41
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 4 · 2020: 2 · 2019: 5 · 2018: 2 · 2017: 8 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 6 · 2012: 3
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- audiogenic seizures, fragile X syndrome, FMR1 gene, Fmr1 knockout mice, gene rescue, transgenic mice, epilepsy, seizure susceptibility
- MeSH terms
- Acoustic Stimulation, Age Factors, Aging, Animals, Brain, Disease Models, Animal, Epilepsy, Fragile X Syndrome, Humans, Transfection, Genetic Therapy, Mice, Knockout, Transgenes, Genetic Predisposition to Disease, Epilepsy, Reflex, Mice, Fragile X Mental Retardation Protein, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review